Pharmaceutical packaging partnership
Schott has confirmed a partnership with West Pharmaceutical Services Inc, a global leader in innovative solutions for injectable drug administration, to combine the Schott iQ platform with West’s Ready Pack system. The collaboration will initially launch by combining West components and Schott’s adaptiQ RTU glass vials and will expand to include other convenient, ready-to-use combinations of products, to be available on a small quantity basis. Further product launch plans will be shared in early 2020.
“With more than 4000 new injectable drug products in development worldwide, many of which are in small settings such as universities, medical research institutes, or smaller-sized companies, West appreciates and understands the need to provide ready-to-use, high quality, sterile packaging products in small volumes for developmental and clinical phases” said Mike Schaefers, Vice President and General Manager, Pharma, West. “Our partnership with Schott now provides our customers with high quality glass containment options to complement the stoppers, seals and glass alternatives West already provides through its Ready Pack system.”
“Easy and fast access to our broad product portfolio of ready-to-use vials and components not only gives flexibility in the drug development and production process but also helps to enhance patient’s safety as an overall target” commented Fabian Stöcker, VP, Global Strategy and Innovation, Schott Pharmaceutical Systems. “Through this partnership, Schott and West have partnered to provide containment solutions to the market that reduce risk and meet increasing regulations across the globe. We worked together to pre-test combinations of Schott’s highest quality ISO vials, with West’s high end sterilised stoppers and seals. Extending this concept to other primary packaging containers such as ready-to-use cartridges and ready-to-use syringes will also benefit our customers using this kind of primary packaging.”